Inhaltsverzeichnis
Auswahl der wissenschaftlichen Literatur zum Thema „Gonadotropin-Releasing hormones“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Gonadotropin-Releasing hormones" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Gonadotropin-Releasing hormones"
Podhorec, P., und J. Kouril. „Induction of final oocyte maturation in Cyprinidae fish by hypothalamic factors: a review“. Veterinární Medicína 54, No. 3 (08.04.2009): 97–110. http://dx.doi.org/10.17221/50/2009-vetmed.
Der volle Inhalt der QuelleSaleh, Ahmed A., Nada N. A. M. Hassanine, Taha K. Taha, Amr M. A. Rashad und Mahmoud A. Sharaby. „Molecular regulation and genetic basis of gonadotropin-releasing hormone genes: A review“. Applied Veterinary Research 2, Nr. 4 (10.10.2023): 2023017. http://dx.doi.org/10.31893/avr.2023017.
Der volle Inhalt der QuelleCrowley, W. R. „Toward Multifactorial Hypothalamic Regulation of Anterior Pituitary Hormone Secretion“. Physiology 14, Nr. 2 (April 1999): 54–58. http://dx.doi.org/10.1152/physiologyonline.1999.14.2.54.
Der volle Inhalt der QuelleKing, Judy A., und Robert P. Millar. „Evolution of gonadotropin-releasing hormones“. Trends in Endocrinology & Metabolism 3, Nr. 9 (November 1992): 339–46. http://dx.doi.org/10.1016/1043-2760(92)90113-f.
Der volle Inhalt der QuelleSHERWOOD, NANCY M., DAVID A. LOVEJOY und IMOGEN R. COE. „Origin of Mammalian Gonadotropin-Releasing Hormones“. Endocrine Reviews 14, Nr. 2 (April 1993): 241–54. http://dx.doi.org/10.1210/edrv-14-2-241.
Der volle Inhalt der QuellePehlivan, Erkan, Hüseyin Polat und Gürsel Dellal. „Annual Change of Reproductive Hormones in Female Angora Goats“. Turkish Journal of Agriculture - Food Science and Technology 5, Nr. 4 (06.04.2017): 343. http://dx.doi.org/10.24925/turjaf.v5i4.343-348.1220.
Der volle Inhalt der QuelleKotlyar, Alexander M., Lubna Pal und Hugh S. Taylor. „Eliminating Hormones With Orally Active Gonadotropin-releasing Hormone Antagonists“. Clinical Obstetrics & Gynecology 64, Nr. 4 (21.10.2021): 837–49. http://dx.doi.org/10.1097/grf.0000000000000664.
Der volle Inhalt der QuelleRichalet, Jean-Paul, Murielle Letournel und Jean-Claude Souberbielle. „Effects of high-altitude hypoxia on the hormonal response to hypothalamic factors“. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 299, Nr. 6 (Dezember 2010): R1685—R1692. http://dx.doi.org/10.1152/ajpregu.00484.2010.
Der volle Inhalt der QuelleMuñoz-Cueto, José A., Nilli Zmora, José A. Paullada-Salmerón, Miranda Marvel, Evaristo Mañanos und Yonathan Zohar. „The gonadotropin-releasing hormones: Lessons from fish“. General and Comparative Endocrinology 291 (Mai 2020): 113422. http://dx.doi.org/10.1016/j.ygcen.2020.113422.
Der volle Inhalt der QuelleChen, Huiqin, Baoliang Bi, Lingfu Kong, Hua Rong, Yanhua Su und Qing Hu. „Seasonal Changes in Plasma Hormones, Sex-Related Genes Transcription in Brain, Liver and Ovary during Gonadal Development in Female Rainbow Trout (Oncorhynchus mykiss)“. Fishes 6, Nr. 4 (12.11.2021): 62. http://dx.doi.org/10.3390/fishes6040062.
Der volle Inhalt der QuelleDissertationen zum Thema "Gonadotropin-Releasing hormones"
Powell, R. C. „Evolution of the structure and function of vertebrate brain gonadotropin-releasing hormone“. Master's thesis, University of Cape Town, 1986. http://hdl.handle.net/11427/27201.
Der volle Inhalt der QuelleVon, Schalburg Kristian Robert. „The gonadotropin-releasing hormone gene : characterization, regulation and expression in two salmonids“. Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp03/NQ36651.pdf.
Der volle Inhalt der QuelleVon, Boetticher S. „Investigating the mechanism of transcriptional regulation of the gonadotropin-releasing hormone receptor (GnRHR) gene by dexamethasone“. Thesis, Link to the online version, 2008. http://hdl.handle.net/10019/1796.
Der volle Inhalt der QuelleAn, Beum-Soo. „Cross-talk between gonadotropin-releasing hormones and progesterone receptor in neuroendocrine cells“. Thesis, University of British Columbia, 2007. http://hdl.handle.net/2429/30705.
Der volle Inhalt der QuelleMedicine, Faculty of
Obstetrics and Gynaecology, Department of
Graduate
Styger, Gustav. „The role of steroidogenic factor-1 (SF-1) in transcriptional regulation of the gonadotropin-releasing hormone (GnRH) receptor gene“. Thesis, Stellenbosch : Stellenbosch University, 2001. http://hdl.handle.net/10019.1/52572.
Der volle Inhalt der QuelleENGLISH ABSTRACT: The GnRH receptor is a G-protein-coupled receptor in pituitary gonadotrope cells. Binding of its ligand, GnRH, results in synthesis and release of gonadotropin hormones luteinizing hormone (LH) and follicle stimulating hormone (FSH). Steroidogenic factor 1 (SF-1), a transcription factor, binds to specific sites in the promoter region of gonadotropin genes, and thus regulates transcription of these genes. The promoter region of the GnRHreceptor gene contains two SF-1-like binding sites, one at -14 to -8 (site 1) and another at -247 to -239 (site 2), relative to the methionine start codon. The role played by these two SF-1-like sites in basal transcription of the mouse GnRH receptor (mGnRH-R) gene in a pituitary precursor gonadotrope cell line, aT3 cells, was the first area of investigation during this study. Luciferase reporter constructs containing 580 bp of mGnRH-R gene promoter were prepared, where SF-1-like sites were either wildtype or mutated. Four such constructs were made, i.e. wildtype (LG), site 1 mutant (LGM1), site 2 mutant (LGM2) and mutated site 1 plus site 2 (LGM1/2). These constructs were transfected into aT3 cells to determine the effect of mutations of sites 1 and/or 2 on the basal expression of the mGnRH-R gene. Mutation of either site 1 or site 2 had no effect on basal expression of the mGnRH-R gene. It was found that only upon simultaneous mutation of both sites 1 and 2, a 50% reduction in basal transcription took place. The implications of this is that SF-1 protein seems to only require one intact DNA-binding site, to mediate basal transcription of the mGnRH-R gene, suggesting that these two sites lie in close proximity during basal transcription. The effect of the protein kinase A (PKA) pathway on the endogenous mGnRH-R gene was also investigated by incubating non- , transfected aT3 cells with the PKA activators, forskolin and 8-Br-cAMP. Similar incubations were also performed on the wild type and mutated site 1 constructs transfected into pituitary gonadotrope aT3 cells. It was found that forskolin and 8-Br-cAMP were able to increase endogenous mGnRH-R mRNA levels in a concentration-dependent fashion, showing that endogenous GnRH receptor gene expression is stimulated via a protein kinase A pathway. Similar results were obtained with the wildtype promoter construct, showing that the protein kinase A pathway stimulates transcription of the promoter. This effect was only seen with wild type and not with the mutated site 1. These results are consistent with a role for a SF-1-like transcription factor in mediating the protein kinase A effect via binding to the site 1 at position -14 in the GnRH receptor gene. A separate investigation was performed to determine whether 25-hydroxycholesterol (25-0HC) is a ligand for SF-1, by incubating aT3 cells transfected with the various constructs with 25-0HC. Results show a dose-dependant response, with an increase in gene expression at 1 μM and a decrease at higher concentrations, for both mutant and wild type constructs. This suggests that, if SF-1 is indeed the protein binding to sites 1 and 2, then 25-0HC is not a ligand for SF-1 protein in aT3 cells and that the effect of 25-0HC on the mGnRH-R gene is not mediated via site 1. The results indicate that these decreases of expression at the higher concentrations may be due to cytotoxic effects. Towards the end of the study the laboratory obtained a luminoskan instrument with automatic dispensing features. Optimisation studies on the luciferase and β-Gal assays were performed on the luminoskan in a bid to decrease experimental error. It was found that automation of these assays resulted in a decrease in experimental error, showing that future researchers could benefit substantially from these optimisation studies.
AFRIKAANSE OPSOMMING: Die GnRH reseptor is 'n G proteïen-gekoppelde reseptor in pituitêre gonadotroopselle. Binding van die ligand, GnRH, lei tot die sintese en vrystelling van die gonadotropien hormone, luteïniserende hormoon (LH) en follikel stimulerende hormoon (FSH). Steroidogeniese faktor-t (SF-1) is 'n transkripsie faktor wat aan spesifieke areas in die promotergebied van die gonadotropien hormone bind, en dus transkripsie van hierdie gene reguleer. Die promotergebied van die GnRH reseptor geen bevat twee SF-1 bindings areas, een by -14 to -8 (area 1) asook by -247 to -239 (area 2), relatief to die metionien beginkodon. Die rol wat hierdie twee SF-1 areas speel in basale transkripsie van die muis GnRH reseptor (mGnRH-R) geen in 'n pituïtêre voorloper gonadotroop sellyn, aT3 selle, was die eerste gebied van ondersoek gedurende hierdie studie. Plasmiede bestaande uit die 580 basispaar mGnRH-R promoter verbind aan 'n lusiferase geen is vervaardig, waar SF-1-soortige areas enersyds onveranderd gelaat is, of gemuteer is. Vier sulke plasmiede is vervaardig, nl. onveranderd (LG), area 1 mutant (LGM1), area 2 mutant (LGM2) en gemuteerde area 1 plus area 2 (LGM1/2). Hierdie plasmiede is gebruik om aT3 selle te transfekteer om die effek van mutasies van areas 1 en/of 2 op die basale ekspressie van die mGnRH-R geen te ondersoek. Daar is gevind dat mutasies van areas 1 of 2 geen effek op basale ekspressie op die bogenoemde geen gehad het nie. Slegs tydens gelyktydige mutasie van areas 1 en 2 het 'n 50% vermindering in basale transkripsie plaasgevind. Die implikasies hiervan is dat die SF-1 proteïen blykbaar slegs een volledige DNA-bindingsarea benodig om basale transkripsie van die mGnRH-R geen te reguleer. Dit wil dus voorkom of hierdie twee areas baie na aan mekaar geposisioneer is tydens basale transkripsie. Die effek van die proteïen kinase A (PKA) roete op die natuurlike mGnRH-R geen is ook ondersoek tydens inkubasie van nie-getransfekteerde aT3 selle met die PKA akiveerders, forskolin en 8-Br-cAMP. Soortgelyke inkubasie is ook gedoen op die onveranderde en gemuteerde area 1 plasmiede wat in aT3 selle getransfekteer is. Daar is gevind dat forskolin en 8-Br-cAMP daarin geslaag het om die natuurlike mGnRH-R geen mRNA vlakke op 'n konsentrasie-afhanklike wyse te vermeerder. Hierdie resultaat dui daarop aan dat die natuurlike mGnRH-R geen se ekspressie gestimuleer kan word via 'n proteïen kinase A roete. Soortgelyke resultate is verkry met die onveranderde promoter plasmied en dit wys ook daarop dat proteïen kinase A transkripsie deur die promoter kan stimuleer. Hierdie effek was slegs aanwesig met die onveranderde en nie met die gemuteerde area 1 plasmied nie. Die resultate stem ooreen met 'n rol vir SF-1 transkripsie faktor in die regulering van proteren kinase A effek deur middel van binding aan die area 1 by posisie -14 in die GnRH-R geen. 'n Afsonderlike ondersoek is gedoen om vas te stel of 25-hidroksiecholesterol (25-0HC) 'n ligand vir SF-1 is deur getransfekteerde aT3 selle met 25-0HC te inkubeer. Resultate toon 'n dosis-afhanklike respons met 'n verhoging in geen ekspressie by 1 μM en 'n verlaging met hoër konsentrasies vir beide onveranderde en gemuteerde plasmiede. Dit impliseer dat, indien SF-1 wel die faktor is wat aan areas 1 en 2 bind, 25-0HC nie die ligand vir SF-1 proteren in aT3 selle is nie en dat die effek van 25-0HC op die mGnRH-R geen nie gereguleer word via area 1 nie. Die verlaging in ekspressie gevind by die hoër konsentrasies is dalk die gevolg van sitotoksiese effekte. Teen die einde van die studie het die laboratorium luminoskan toerusting met outomatiese pipettering verkry. Optimiseringstudies van die lusifirase en β-Galtoetse is met die luminoskan gedoen in 'n poging om eksperimentele foute te minimaliseer. Daar is gevind dat outomatisering van hierdie toetse wel gelei het tot 'n verlaging in eksperimentele foute. Toekomstige navorsers kan dus grootliks voordeel trek uit hierdie optimiseringstudies.
Wormald, Patricia J. „GnRH and neuropeptide regulation of gonadotropin secretion from cultured human pituitary cells“. Doctoral thesis, University of Cape Town, 1988. http://hdl.handle.net/11427/27168.
Der volle Inhalt der QuelleDromey, Jasmin Rachel. „Elucidating novel aspects of hypothalamic releasing hormone receptor regulation“. University of Western Australia. School of Medicine and Pharmacology, 2008. http://theses.library.uwa.edu.au/adt-WU2008.0133.
Der volle Inhalt der QuelleKaplan, Hilton. „The control of prolactin secretion and the role of gonadotrophin releasing hormone in the production of concordant secretory spikes of luteinizing hormone and prolactin in the luteal phase of the menstrual cycle“. Master's thesis, University of Cape Town, 1988. http://hdl.handle.net/11427/27203.
Der volle Inhalt der QuelleDe, Villiers Charon. „The effect of gonadotropin-releasing hormones (GnRH) I & II on sperm motility and acrosome status of the Vervet monkey (Chlorocebus aethiops) in vitro“. Thesis, University of the Western Cape, 2006. http://etd.uwc.ac.za/index.php?module=etd&action=viewtitle&id=gen8Srv25Nme4_9134_1253841818.
Der volle Inhalt der QuelleGonadotropin Releasing Hormone (GnRH) is a hypothalmic decapeptide, which regulates mammalian gonadotropin secretions by binding to specific, high affinity receptors in the pituitary. Two forms of GnRH (GnRH I and GnRH II) are expressed in the brain of human and some primates. Even though primates have been used extensively in a variety of investigations in relation to the role of GnRH in reproduction, there is no evidence of any research to investigate the direct effect of GnRH on primate sperm.
Jeanne, Fabian. „Evοlutiοns des systèmes GΝRΗ et des hοrmοnes glycοprοtéiques dans les cοntrôles endοcrine et paracrine de la spermatοgénèse chez la rοussette, Scyliοrhinus canicula“. Electronic Thesis or Diss., Normandie, 2024. http://www.theses.fr/2024NORMC225.
Der volle Inhalt der QuelleSpermatogenesis is a highly specialized process of cell proliferation and differentiation leading to the production of haploid spermatozoa from diploid spermatogonial stem cells. In Gnathostomes, testicular functions are mainly controlled by the endocrine hypothalamic-pituitary-gonadal (HHG) axis, involving hypothalamic GnRHs and the gonadotropic hormones FSH and LH, which emerged at the root of cartilaginous vertebrates. In addition, paracrine functions of GnRHs and thyrostimulin have been explored at the gonadic level in bony vertebrates. The aim of this thesis was to characterize the endocrine and paracrine regulation of spermatogenesis exerted by GnRHs and gonadotropic hormones in an Elasmobranch model, the catshark Scyliorhinus canicula. This work has been extended to the characterization of GPA2 and GPB5, constituting thyrostimulin, which correspond to orthologs of the molecular ancestors of glycoprotein hormone subunits. In this work, the evolution of the testicular proteome during spermatogenesis in S. canicula was described, and the neuropeptides GnRHs, the glycoprotein hormones FSH, LH, TSH, GPA2 and GPB5, as well as their associated receptors were studied by in silico and expression analyses in different tissues, with a focus on spermatogenesis. Expressions were observed at all stages of spermatogenesis for fshr, lhr and GnRH receptors associated at germinal and sertolian levels, for tshr and gpb5 at sertolian level and for gpa2 at germinal level, with higher abundances associated with spermatid stages. This work was complemented by in vitro functional tests which showed that FSHR could be activated by FSH and LH, LHR only by LH, and that GPB5-GPA2 could activate all three receptors FSHR, LHR and TSHR, suggesting a paracrine role for thyrostimulin at the testicular level. Taken together, this work proposes a model for the regulation of spermatogenesis in Elasmobranchs that combines endocrine hormones, with circulating GnRHs and gonadotropins, and paracrine hormones, with GPA2, GPB5 and steroids. This model appears consistent and intermediate in the evolution of spermatogenesis regulating systems, which has shift from predominantly paracrine regulation in non-vertebrate bilaterians to predominantly endocrine regulation in bony vertebrates, with the establishment of the hypothalamic-pituitary-gonadal axis
Bücher zum Thema "Gonadotropin-Releasing hormones"
L, Barbieri Robert, und Friedman Andrew J, Hrsg. Gonadotropin releasing hormone analogs: Applications in gynecology. New York: Elsevier, 1991.
Den vollen Inhalt der Quelle findenOrganon Round Table Conference (3rd 1992 Paris, France). GnRH, GnRH analogs, gonadotropins, and gonadal peptides: The proceedings of the third Organon Round Table Conference, Paris, 1992. London: Parthenon Pub. Group, 1993.
Den vollen Inhalt der Quelle findenFerring Symposium on Brain and Pituitary Peptides (3rd 1985 Noordwijk, Netherlands). Pulsatile GnRH 1985: Proceedings of the 3rd Ferring Symposium, Noordwijk, September 11-13, 1985. Herausgegeben von Coelingh Bennink, Herman Jan Tymen, 1943-. Haarlem: Ferring, 1985.
Den vollen Inhalt der Quelle findenJan, Horský. Gonadotropin-releasing hormone and ovarian function. Prague: Avicenum, Czechoslovak Medical Press, 1986.
Den vollen Inhalt der Quelle finden1958-, Parhar Ishwar S., Hrsg. Gonadotropin-releasing hormone: Molecules and receptors. Amsterdam: Elsevier, 2002.
Den vollen Inhalt der Quelle findenGoodman, Stephanie Robin. Effects of gonadotrophin releasing hormone on growth hormone release in the rat. [New Haven, Conn: s.n.], 1993.
Den vollen Inhalt der Quelle findenWorld, Congress on Fertility and Sterility (15th 1995 Bologna Italy). Treatment with GnRH analogs: Controversies and perspectives : the proceedings of a satellite symposium of the 15th World Congress on Fertility and Sterility held in Bologna, Italy, 15-16 September 1995. New York: Parthenon Pub. Group, 1996.
Den vollen Inhalt der Quelle findenNyean, Lee Chin, Hrsg. Using gonadotropin-releasing hormone (GnRH) to improve dairy cattle conception rates in the tropics. [Honolulu]: HITAHR, College of Tropical Agriculture and Human Resources, University of Hawaii, 1989.
Den vollen Inhalt der Quelle findenGore, Andrea C. GnRH, the master molecule of reproduction. Boston: Kluwer Academic Publishers, 2002.
Den vollen Inhalt der Quelle findenGore, Andrea C. GnRH, the master molecule of reproduction. Boston: Kluwer Academic Publishers, 2002.
Den vollen Inhalt der Quelle findenBuchteile zum Thema "Gonadotropin-Releasing hormones"
Sherwood, Nancy. „Gonadotropin-Releasing Hormones in Fishes“. In Hormones and Reproduction in Fishes, Amphibians, and Reptiles, 31–60. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1869-9_2.
Der volle Inhalt der QuelleMoghissi, Kamran S. „Gonadotropin Releasing Hormones: Physiopathology and Clinical Applications“. In The Brain as an Endocrine Organ, 1–13. New York, NY: Springer New York, 1989. http://dx.doi.org/10.1007/978-1-4612-3480-7_1.
Der volle Inhalt der QuelleLicht, Paul, und David A. Porter. „Role of Gonadotropin-Releasing Hormone in Regulation of Gonadotropin Secretion from Amphibian and Reptilian Pituitaries“. In Hormones and Reproduction in Fishes, Amphibians, and Reptiles, 61–85. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1869-9_3.
Der volle Inhalt der QuelleManji, Husseini K., Jorge Quiroz, R. Andrew Chambers, Anthony Absalom, David Menon, Patrizia Porcu, A. Leslie Morrow et al. „Gonadotropin-Releasing Hormone“. In Encyclopedia of Psychopharmacology, 561. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_1886.
Der volle Inhalt der QuelleNaor, Zvi, und Rony Seger. „Gonadotropin-Releasing Hormone“. In Encyclopedia of Cancer, 1–4. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-27841-9_2477-2.
Der volle Inhalt der QuelleNaor, Zvi, und Rony Seger. „Gonadotropin-Releasing Hormone“. In Encyclopedia of Cancer, 1938–41. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-46875-3_2477.
Der volle Inhalt der QuelleNaor, Zvi, und Rony Seger. „Gonadotropin-Releasing Hormone“. In Encyclopedia of Cancer, 1577–80. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_2477.
Der volle Inhalt der QuelleBidlingmaier, M. „Gonadotropin-Releasing-Hormon“. In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_1312-1.
Der volle Inhalt der QuelleBidlingmaier, M. „Gonadotropin-Releasing-Hormon“. In Springer Reference Medizin, 1014. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_1312.
Der volle Inhalt der QuelleColao, Annamaria, und Claudia Pivonello. „Gonadotropin Releasing Hormone (GnRH)“. In Encyclopedia of Pathology, 1–2. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-319-28845-1_5110-1.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Gonadotropin-Releasing hormones"
Ohlsson, M., A. J. W. Hsueh und T. Ny. „HORMONE REGULATION OF THE FIBRINOLYTIC SYSTEM IN THE OVARY“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644389.
Der volle Inhalt der QuelleSand, Sharon R., Catherine Klifa, Michael F. Press, Malcolm Pike, Giske Ursin, Darcy Spicer, Lalit Vora et al. „Abstract 3557: Reduced ovarian hormones & reduced mammographic & MRI determined breast density inBRCAcarriers following a hormonal chemo-prevention regimen of gonadotropin releasing hormone agonist (GnRHA) & low-dose add-back estrogen & testosterone“. In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-3557.
Der volle Inhalt der Quelle„TOWARDS A NEW HOMOGENEOUS IMMUNOASSAY FOR GONADOTROPIN-RELEASING HORMONE BASED ON TIME-RESOLVED FLUORESCENCE ANISOTROPY“. In International Conference on Biomedical Electronics and Devices. SciTePress - Science and and Technology Publications, 2011. http://dx.doi.org/10.5220/0003152001840188.
Der volle Inhalt der QuelleBibiari, Georgia, Agathi Nteli, Carmen Simal, Christos Markatos, Vlasios Karageorgos, Alexios Vlamis-Gardikas, George Liapakis und Theodore Tselios. „Design and Synthesis of Gonadotropin Releasing Hormone (GnRH) Peptide Analogues Conjugated with Anthraquinone for Selective Immunosuppression“. In 36th European Peptide Symposium. The European Peptide Society, 2022. http://dx.doi.org/10.17952/36eps.2022.065.
Der volle Inhalt der QuelleBiniari, Georgia, Agathi Nteli, Carmen Simal, Christos Markatos, Vlasios Karageorgos, Alexios Vlamis-Gardikas, George Liapakis und Theodore Tselios. „Design and Synthesis of Gonadotropin Releasing Hormone (GnRH) Peptide Analogues Conjugated with Anthraquinone for Selective Immunosuppression“. In 36th European Peptide Symposium. The European Peptide Society, 2022. http://dx.doi.org/10.17952/36eps/36eps.2022.065.
Der volle Inhalt der QuelleBiniari, Georgia, Agathi Nteli, Christos Markatos, Vlasios Karageorgos, Alexios Vlamis-Gardikas, George Liapakis, Maria Venihaki, Theodore Tselios und Carmen Simal. „Rational design, synthesis and evaluation of mitoxantrone conjugated with mutated Gonadotropin Releasing Hormone (GnRH) for the treatment of hormone-dependent cancer“. In 37th European Peptide Symposium, 1216. The European Peptide Society, 2024. http://dx.doi.org/10.17952/37eps.2024.p1216.
Der volle Inhalt der QuellePacucci, VA, F. Ceccarelli, G. Perrone, I. Zannini, M. Candelieri, I. Leccese, C. Perricone et al. „SAT0260 Ovarian function preservation with gonadotropin-releasing hormone analogues in patients with systemic lupus erythematosus treated with cyclophosphamide“. In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.6381.
Der volle Inhalt der QuelleKim, HJ, MH Lee, JE Lee, SH Park, ES Lee, Y.-J. Kang, JH Lee et al. „Abstract P1-12-09: The oncologic effect of a gonadotropin releasing hormone (GnRH) agonist for ovarian protection during breast cancer chemotherapy“. In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p1-12-09.
Der volle Inhalt der QuelleXue, Yu, Youting Dong und Xiaojun Chen. „PR001/#476 Gonadotropin-releasing hormone agonist (GnRH-a) plus letrozole in young women with early endometrial cancer: a prospective randomized controlled trial“. In IGCS 2024 Annual Meeting Abstracts, A37.1—A37. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/ijgc-2024-igcs.43.
Der volle Inhalt der QuelleYoon, TI, HJ Kim, JH Yu, G. Sohn, BS Ko, JW Lee, BH Son und SH Ahn. „Abstract P5-13-06: Concurrent gonadotropin-releasing hormone (GnRH) agonist administration with chemotherapy improves neoadjuvant chemotherapy responses in young premenopausal breast cancer patients“. In Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.sabcs15-p5-13-06.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "Gonadotropin-Releasing hormones"
Zohar, Yonathan, Robert Langer, Shimon Hassin, Walton Dickhoff, Abigail Elizur und Yoav Gothilf. A Novel Technology for the Manipulation of Fish Reproductive Cycles: Controlled Release of Gonadotropin Releasing Hormones. United States Department of Agriculture, März 1993. http://dx.doi.org/10.32747/1993.7603811.bard.
Der volle Inhalt der QuelleXu, Dan, Xueying Zhou, Junfei Wang, Xi Cao und Tao Liu. The Value of Urinary Gonadotropins in the Diagnosis of Central Precocious Puberty: A Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Dezember 2021. http://dx.doi.org/10.37766/inplasy2021.12.0076.
Der volle Inhalt der QuelleGu, Li, Xurui Li und Wentao Liu. Adverse cardiovascular effect following Gonadotropin-releasing Hormone (GnRH) antagonist versus GnRH agonist for Prostate Cancer Treatment: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Februar 2023. http://dx.doi.org/10.37766/inplasy2023.2.0009.
Der volle Inhalt der QuelleYaron, Zvi, Abigail Elizur, Martin Schreibman und Yonathan Zohar. Advancing Puberty in the Black Carp (Mylopharyngodon piceus) and the Striped Bass (Morone saxatilis). United States Department of Agriculture, Januar 2000. http://dx.doi.org/10.32747/2000.7695841.bard.
Der volle Inhalt der Quelle